ImmuCell Corp (NAS:ICCC)
$ 5.17 -0.24 (-4.44%) Market Cap: 46.07 Mil Enterprise Value: 57.80 Mil PE Ratio: 0 PB Ratio: 1.73 GF Score: 67/100

Q3 2024 ImmuCell Corp Earnings Call Transcript

Nov 14, 2024 / 02:00PM GMT
Release Date Price: $3.6 (+1.98%)
Operator

Good morning and welcome to ImmuCell Corporation reports third quarter September 30, 2024, unaudited financial results conference call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference call over to Joe Diaz of Lytham Partners. Please go ahead.

Joe Diaz
Lytham Partners LLC - Analyst

Thank you, Wyatt, and good morning and welcome to everybody on today's call. As the conference call operator indicated, my name is Joe Diaz with Lytham Partners. We're the Investor Relations consulting firm for ImmuCell. I thank all of you for joining us today to discuss the unaudited financial results for the quarter ended September 30, 2024.

Listeners are reminded and cautioned that statements made by management during the course of this call include forward-looking statements, which include any statements that refer to future events or expected future results or predictions about the steps the company plans to take in the future. These statements are not guarantees of performance and are subject to risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot